Peter Mӧller

19.8k citations
205 papers · 9.8k · 2 hit papers · h-index 52

Impact in

Papers in

Peter Mӧller

200 papers receiving 9.6k citations

Peter Mӧller's Hit Papers

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma 2013 · 373 citations
3730+12+24Years since publication4008001.2k

Peers

Peter Mӧller
Comparison fields: 5 of 146
  • Pathology and Forensic Medicine 3.4k
  • Genetics 1.4k
  • Oncology 2.9k
  • Immunology 2.2k
  • Cancer Research 940
Replace Reza Parwaresch with:
Reza Parwaresch Germany
Hilmar Lemke Germany
Peter Marynen Belgium
Giorgio Cattoretti Italy
Ahmet Doǧan United States
R. S. K. Chaganti United States
Denise Sheer United Kingdom
Jeffrey Sklar United States
Magnus Nordenskjöld Sweden
Ad Geurts van Kessel Netherlands
Peter Mӧller relative to Reza Parwaresch Germany Reza Parwaresch's profile →
Citations per field
00.5×3.2×
Reza Parwaresch · 1×
Citations per year

Countries citing papers authored by Peter Mӧller

Since Specialization
Citations

This map shows the geographic impact of Peter Mӧller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mӧller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mӧller more than expected).

Fields of papers citing papers by Peter Mӧller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mӧller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mӧller. The network helps show where Peter Mӧller may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Mӧller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Mӧller Line = papers co-authored together Peter Mӧller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Hit paper breakdown →
19891478
2
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Hit paper breakdown →
2013373
3 2007357
4 1996254
5 2006228
6 2005214
7
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.
2000212
8 2002173
9 2006164
10
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
1991150
11 2001148
12 2010145
13 2002141
14 2005136
15 2003130
16
T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
1998128
17 1997114
18 2003114
19 1990114
20 2013113

About Peter Mӧller

Peter Mӧller is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Genetics and Pulmonary and Respiratory Medicine, having authored 205 papers that have together received 9.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (95 papers), Chronic Lymphocytic Leukemia Research (38 papers), Immune Cell Function and Interaction (26 papers), Viral-associated cancers and disorders (24 papers), Sarcoma Diagnosis and Treatment (19 papers), Bone Tumor Diagnosis and Treatments (17 papers), Genetic factors in colorectal cancer (16 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Genetics (1.4k citations), Oncology (2.9k citations), Immunology (2.2k citations) and Cancer Research (940 citations). Peter Mӧller has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Thomas F.E. Barth, Peter H. Krammer, S. Matzku, Werner Falk, Anke Peters, C Klas, Klaus‐Michael Debatin, Silke Brüderlein, Martin Bentz and Peter Lichter. Their work appears in journals such as Blood, International Journal of Cancer, British Journal of Haematology, Genes Chromosomes and Cancer and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact